U.S. insurers squeeze diabetes drug prices : Eli Lilly

January 13, 2015 12:11 AM

9 0

SAN FRANCISCO (Reuters) - Eli Lilly and Co said on Monday that U.S. insurers are increasing pressure on the price of diabetes medications as they switch coverage from certain drugs to others to trim costs.

At the same time, Lilly's financial chief believes its products produce better results for patients and will help the company, which is one of the largest diabetes drugmakers, withstand the pressure.

Read more

To category page